Correlation Between SOFI TECHNOLOGIES and Diamyd Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SOFI TECHNOLOGIES and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SOFI TECHNOLOGIES and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SOFI TECHNOLOGIES and Diamyd Medical AB, you can compare the effects of market volatilities on SOFI TECHNOLOGIES and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SOFI TECHNOLOGIES with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SOFI TECHNOLOGIES and Diamyd Medical.

Diversification Opportunities for SOFI TECHNOLOGIES and Diamyd Medical

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SOFI and Diamyd is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding SOFI TECHNOLOGIES and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and SOFI TECHNOLOGIES is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SOFI TECHNOLOGIES are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of SOFI TECHNOLOGIES i.e., SOFI TECHNOLOGIES and Diamyd Medical go up and down completely randomly.

Pair Corralation between SOFI TECHNOLOGIES and Diamyd Medical

Assuming the 90 days horizon SOFI TECHNOLOGIES is expected to generate 0.79 times more return on investment than Diamyd Medical. However, SOFI TECHNOLOGIES is 1.27 times less risky than Diamyd Medical. It trades about 0.52 of its potential returns per unit of risk. Diamyd Medical AB is currently generating about 0.1 per unit of risk. If you would invest  1,021  in SOFI TECHNOLOGIES on September 5, 2024 and sell it today you would earn a total of  502.00  from holding SOFI TECHNOLOGIES or generate 49.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

SOFI TECHNOLOGIES  vs.  Diamyd Medical AB

 Performance 
       Timeline  
SOFI TECHNOLOGIES 

Risk-Adjusted Performance

29 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in SOFI TECHNOLOGIES are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, SOFI TECHNOLOGIES reported solid returns over the last few months and may actually be approaching a breakup point.
Diamyd Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

SOFI TECHNOLOGIES and Diamyd Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SOFI TECHNOLOGIES and Diamyd Medical

The main advantage of trading using opposite SOFI TECHNOLOGIES and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SOFI TECHNOLOGIES position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.
The idea behind SOFI TECHNOLOGIES and Diamyd Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world